Global Dengue Vaccines Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The global Dengue Vaccines market size is projected to grow from US$ 512 million in 2024 to US$ 1174 million in 2030; it is expected to grow at a CAGR of 14.8% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Dengue Vaccines Industry Forecast” looks at past sales and reviews total world Dengue Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Dengue Vaccines sales for 2023 through 2029. With Dengue Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dengue Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Dengue Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dengue Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dengue Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dengue Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dengue Vaccines.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report presents a comprehensive overview, market shares, and growth opportunities of Dengue Vaccines market by product type, application, key players and key regions and countries.
Segmentation by Type:
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The global Dengue Vaccines market size is projected to grow from US$ 512 million in 2024 to US$ 1174 million in 2030; it is expected to grow at a CAGR of 14.8% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Dengue Vaccines Industry Forecast” looks at past sales and reviews total world Dengue Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Dengue Vaccines sales for 2023 through 2029. With Dengue Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dengue Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Dengue Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dengue Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dengue Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dengue Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dengue Vaccines.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report presents a comprehensive overview, market shares, and growth opportunities of Dengue Vaccines market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Dengvaxia
- TAK-003
- Others
- Public Sector
- Private Sector
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dengvaxia
- TAK-003
- Others
- Public Sector
- Private Sector
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Takeda
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dengue Vaccines Market Size 2019-2030
2.1.2 Dengue Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Dengue Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Dengue Vaccines Segment by Type
2.2.1 Dengvaxia
2.2.2 TAK-003
2.2.3 Others
2.3 Dengue Vaccines Market Size by Type
2.3.1 Dengue Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dengue Vaccines Market Size Market Share by Type (2019-2024)
2.4 Dengue Vaccines Segment by Application
2.4.1 Public Sector
2.4.2 Private Sector
2.5 Dengue Vaccines Market Size by Application
2.5.1 Dengue Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dengue Vaccines Market Size Market Share by Application (2019-2024)
3 DENGUE VACCINES MARKET SIZE BY PLAYER
3.1 Dengue Vaccines Market Size Market Share by Player
3.1.1 Global Dengue Vaccines Revenue by Player (2019-2024)
3.1.2 Global Dengue Vaccines Revenue Market Share by Player (2019-2024)
3.2 Global Dengue Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DENGUE VACCINES BY REGION
4.1 Dengue Vaccines Market Size by Region (2019-2024)
4.2 Global Dengue Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Dengue Vaccines Market Size Growth (2019-2024)
4.4 APAC Dengue Vaccines Market Size Growth (2019-2024)
4.5 Europe Dengue Vaccines Market Size Growth (2019-2024)
4.6 Middle East & Africa Dengue Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Dengue Vaccines Market Size by Country (2019-2024)
5.2 Americas Dengue Vaccines Market Size by Type (2019-2024)
5.3 Americas Dengue Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dengue Vaccines Market Size by Region (2019-2024)
6.2 APAC Dengue Vaccines Market Size by Type (2019-2024)
6.3 APAC Dengue Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Dengue Vaccines Market Size by Country (2019-2024)
7.2 Europe Dengue Vaccines Market Size by Type (2019-2024)
7.3 Europe Dengue Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dengue Vaccines by Region (2019-2024)
8.2 Middle East & Africa Dengue Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa Dengue Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DENGUE VACCINES MARKET FORECAST
10.1 Global Dengue Vaccines Forecast by Region (2025-2030)
10.1.1 Global Dengue Vaccines Forecast by Region (2025-2030)
10.1.2 Americas Dengue Vaccines Forecast
10.1.3 APAC Dengue Vaccines Forecast
10.1.4 Europe Dengue Vaccines Forecast
10.1.5 Middle East & Africa Dengue Vaccines Forecast
10.2 Americas Dengue Vaccines Forecast by Country (2025-2030)
10.2.1 United States Market Dengue Vaccines Forecast
10.2.2 Canada Market Dengue Vaccines Forecast
10.2.3 Mexico Market Dengue Vaccines Forecast
10.2.4 Brazil Market Dengue Vaccines Forecast
10.3 APAC Dengue Vaccines Forecast by Region (2025-2030)
10.3.1 China Dengue Vaccines Market Forecast
10.3.2 Japan Market Dengue Vaccines Forecast
10.3.3 Korea Market Dengue Vaccines Forecast
10.3.4 Southeast Asia Market Dengue Vaccines Forecast
10.3.5 India Market Dengue Vaccines Forecast
10.3.6 Australia Market Dengue Vaccines Forecast
10.4 Europe Dengue Vaccines Forecast by Country (2025-2030)
10.4.1 Germany Market Dengue Vaccines Forecast
10.4.2 France Market Dengue Vaccines Forecast
10.4.3 UK Market Dengue Vaccines Forecast
10.4.4 Italy Market Dengue Vaccines Forecast
10.4.5 Russia Market Dengue Vaccines Forecast
10.5 Middle East & Africa Dengue Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt Market Dengue Vaccines Forecast
10.5.2 South Africa Market Dengue Vaccines Forecast
10.5.3 Israel Market Dengue Vaccines Forecast
10.5.4 Turkey Market Dengue Vaccines Forecast
10.6 Global Dengue Vaccines Forecast by Type (2025-2030)
10.7 Global Dengue Vaccines Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Dengue Vaccines Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Dengue Vaccines Product Offered
11.1.3 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Dengue Vaccines Product Offered
11.2.3 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Takeda Main Business Overview
11.2.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dengue Vaccines Market Size 2019-2030
2.1.2 Dengue Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Dengue Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Dengue Vaccines Segment by Type
2.2.1 Dengvaxia
2.2.2 TAK-003
2.2.3 Others
2.3 Dengue Vaccines Market Size by Type
2.3.1 Dengue Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Dengue Vaccines Market Size Market Share by Type (2019-2024)
2.4 Dengue Vaccines Segment by Application
2.4.1 Public Sector
2.4.2 Private Sector
2.5 Dengue Vaccines Market Size by Application
2.5.1 Dengue Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Dengue Vaccines Market Size Market Share by Application (2019-2024)
3 DENGUE VACCINES MARKET SIZE BY PLAYER
3.1 Dengue Vaccines Market Size Market Share by Player
3.1.1 Global Dengue Vaccines Revenue by Player (2019-2024)
3.1.2 Global Dengue Vaccines Revenue Market Share by Player (2019-2024)
3.2 Global Dengue Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DENGUE VACCINES BY REGION
4.1 Dengue Vaccines Market Size by Region (2019-2024)
4.2 Global Dengue Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Dengue Vaccines Market Size Growth (2019-2024)
4.4 APAC Dengue Vaccines Market Size Growth (2019-2024)
4.5 Europe Dengue Vaccines Market Size Growth (2019-2024)
4.6 Middle East & Africa Dengue Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Dengue Vaccines Market Size by Country (2019-2024)
5.2 Americas Dengue Vaccines Market Size by Type (2019-2024)
5.3 Americas Dengue Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dengue Vaccines Market Size by Region (2019-2024)
6.2 APAC Dengue Vaccines Market Size by Type (2019-2024)
6.3 APAC Dengue Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Dengue Vaccines Market Size by Country (2019-2024)
7.2 Europe Dengue Vaccines Market Size by Type (2019-2024)
7.3 Europe Dengue Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dengue Vaccines by Region (2019-2024)
8.2 Middle East & Africa Dengue Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa Dengue Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DENGUE VACCINES MARKET FORECAST
10.1 Global Dengue Vaccines Forecast by Region (2025-2030)
10.1.1 Global Dengue Vaccines Forecast by Region (2025-2030)
10.1.2 Americas Dengue Vaccines Forecast
10.1.3 APAC Dengue Vaccines Forecast
10.1.4 Europe Dengue Vaccines Forecast
10.1.5 Middle East & Africa Dengue Vaccines Forecast
10.2 Americas Dengue Vaccines Forecast by Country (2025-2030)
10.2.1 United States Market Dengue Vaccines Forecast
10.2.2 Canada Market Dengue Vaccines Forecast
10.2.3 Mexico Market Dengue Vaccines Forecast
10.2.4 Brazil Market Dengue Vaccines Forecast
10.3 APAC Dengue Vaccines Forecast by Region (2025-2030)
10.3.1 China Dengue Vaccines Market Forecast
10.3.2 Japan Market Dengue Vaccines Forecast
10.3.3 Korea Market Dengue Vaccines Forecast
10.3.4 Southeast Asia Market Dengue Vaccines Forecast
10.3.5 India Market Dengue Vaccines Forecast
10.3.6 Australia Market Dengue Vaccines Forecast
10.4 Europe Dengue Vaccines Forecast by Country (2025-2030)
10.4.1 Germany Market Dengue Vaccines Forecast
10.4.2 France Market Dengue Vaccines Forecast
10.4.3 UK Market Dengue Vaccines Forecast
10.4.4 Italy Market Dengue Vaccines Forecast
10.4.5 Russia Market Dengue Vaccines Forecast
10.5 Middle East & Africa Dengue Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt Market Dengue Vaccines Forecast
10.5.2 South Africa Market Dengue Vaccines Forecast
10.5.3 Israel Market Dengue Vaccines Forecast
10.5.4 Turkey Market Dengue Vaccines Forecast
10.6 Global Dengue Vaccines Forecast by Type (2025-2030)
10.7 Global Dengue Vaccines Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Dengue Vaccines Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Dengue Vaccines Product Offered
11.1.3 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Dengue Vaccines Product Offered
11.2.3 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Takeda Main Business Overview
11.2.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dengue Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Dengue Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Dengvaxia
Table 4. Major Players of TAK-003
Table 5. Major Players of Others
Table 6. Dengue Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Dengue Vaccines Market Size Market Share by Type (2019-2024)
Table 9. Dengue Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Dengue Vaccines Market Size Market Share by Application (2019-2024)
Table 12. Global Dengue Vaccines Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Dengue Vaccines Revenue Market Share by Player (2019-2024)
Table 14. Dengue Vaccines Key Players Head office and Products Offered
Table 15. Dengue Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Dengue Vaccines Market Size Market Share by Region (2019-2024)
Table 20. Global Dengue Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Dengue Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Dengue Vaccines Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Dengue Vaccines Market Size Market Share by Country (2019-2024)
Table 24. Americas Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Dengue Vaccines Market Size Market Share by Type (2019-2024)
Table 26. Americas Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Dengue Vaccines Market Size Market Share by Application (2019-2024)
Table 28. APAC Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Dengue Vaccines Market Size Market Share by Region (2019-2024)
Table 30. APAC Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Dengue Vaccines Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Dengue Vaccines Market Size Market Share by Country (2019-2024)
Table 34. Europe Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Dengue Vaccines
Table 40. Key Market Challenges & Risks of Dengue Vaccines
Table 41. Key Industry Trends of Dengue Vaccines
Table 42. Global Dengue Vaccines Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Dengue Vaccines Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Dengue Vaccines Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Dengue Vaccines Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Sanofi Details, Company Type, Dengue Vaccines Area Served and Its Competitors
Table 47. Sanofi Dengue Vaccines Product Offered
Table 48. Sanofi Dengue Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Sanofi Main Business
Table 50. Sanofi Latest Developments
Table 51. Takeda Details, Company Type, Dengue Vaccines Area Served and Its Competitors
Table 52. Takeda Dengue Vaccines Product Offered
Table 53. Takeda Dengue Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
Table 1. Dengue Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Dengue Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Dengvaxia
Table 4. Major Players of TAK-003
Table 5. Major Players of Others
Table 6. Dengue Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Dengue Vaccines Market Size Market Share by Type (2019-2024)
Table 9. Dengue Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Dengue Vaccines Market Size Market Share by Application (2019-2024)
Table 12. Global Dengue Vaccines Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Dengue Vaccines Revenue Market Share by Player (2019-2024)
Table 14. Dengue Vaccines Key Players Head office and Products Offered
Table 15. Dengue Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Dengue Vaccines Market Size Market Share by Region (2019-2024)
Table 20. Global Dengue Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Dengue Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Dengue Vaccines Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Dengue Vaccines Market Size Market Share by Country (2019-2024)
Table 24. Americas Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Dengue Vaccines Market Size Market Share by Type (2019-2024)
Table 26. Americas Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Dengue Vaccines Market Size Market Share by Application (2019-2024)
Table 28. APAC Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Dengue Vaccines Market Size Market Share by Region (2019-2024)
Table 30. APAC Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Dengue Vaccines Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Dengue Vaccines Market Size Market Share by Country (2019-2024)
Table 34. Europe Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Dengue Vaccines Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Dengue Vaccines Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Dengue Vaccines Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Dengue Vaccines
Table 40. Key Market Challenges & Risks of Dengue Vaccines
Table 41. Key Industry Trends of Dengue Vaccines
Table 42. Global Dengue Vaccines Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Dengue Vaccines Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Dengue Vaccines Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Dengue Vaccines Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Sanofi Details, Company Type, Dengue Vaccines Area Served and Its Competitors
Table 47. Sanofi Dengue Vaccines Product Offered
Table 48. Sanofi Dengue Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Sanofi Main Business
Table 50. Sanofi Latest Developments
Table 51. Takeda Details, Company Type, Dengue Vaccines Area Served and Its Competitors
Table 52. Takeda Dengue Vaccines Product Offered
Table 53. Takeda Dengue Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Dengue Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dengue Vaccines Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Dengue Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Dengue Vaccines Sales Market Share by Country/Region (2023)
Figure 8. Dengue Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Dengue Vaccines Market Size Market Share by Type in 2023
Figure 10. Dengue Vaccines in Public Sector
Figure 11. Global Dengue Vaccines Market: Public Sector (2019-2024) & ($ millions)
Figure 12. Dengue Vaccines in Private Sector
Figure 13. Global Dengue Vaccines Market: Private Sector (2019-2024) & ($ millions)
Figure 14. Global Dengue Vaccines Market Size Market Share by Application in 2023
Figure 15. Global Dengue Vaccines Revenue Market Share by Player in 2023
Figure 16. Global Dengue Vaccines Market Size Market Share by Region (2019-2024)
Figure 17. Americas Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 18. APAC Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 19. Europe Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 21. Americas Dengue Vaccines Value Market Share by Country in 2023
Figure 22. United States Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Dengue Vaccines Market Size Market Share by Region in 2023
Figure 27. APAC Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 28. APAC Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 29. China Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 33. India Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Dengue Vaccines Market Size Market Share by Country in 2023
Figure 36. Europe Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 37. Europe Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 38. Germany Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 39. France Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Dengue Vaccines Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 52. APAC Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 53. Europe Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 55. United States Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 56. Canada Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 57. Mexico Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 58. Brazil Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 59. China Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 60. Japan Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 61. Korea Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 63. India Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 64. Australia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 65. Germany Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 66. France Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 67. UK Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 68. Italy Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 69. Russia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 70. Egypt Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 71. South Africa Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 72. Israel Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 73. Turkey Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 75. Global Dengue Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Dengue Vaccines Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Dengue Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dengue Vaccines Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Dengue Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Dengue Vaccines Sales Market Share by Country/Region (2023)
Figure 8. Dengue Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Dengue Vaccines Market Size Market Share by Type in 2023
Figure 10. Dengue Vaccines in Public Sector
Figure 11. Global Dengue Vaccines Market: Public Sector (2019-2024) & ($ millions)
Figure 12. Dengue Vaccines in Private Sector
Figure 13. Global Dengue Vaccines Market: Private Sector (2019-2024) & ($ millions)
Figure 14. Global Dengue Vaccines Market Size Market Share by Application in 2023
Figure 15. Global Dengue Vaccines Revenue Market Share by Player in 2023
Figure 16. Global Dengue Vaccines Market Size Market Share by Region (2019-2024)
Figure 17. Americas Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 18. APAC Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 19. Europe Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Dengue Vaccines Market Size 2019-2024 ($ millions)
Figure 21. Americas Dengue Vaccines Value Market Share by Country in 2023
Figure 22. United States Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Dengue Vaccines Market Size Market Share by Region in 2023
Figure 27. APAC Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 28. APAC Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 29. China Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 33. India Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Dengue Vaccines Market Size Market Share by Country in 2023
Figure 36. Europe Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 37. Europe Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 38. Germany Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 39. France Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Dengue Vaccines Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Dengue Vaccines Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Dengue Vaccines Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Dengue Vaccines Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 52. APAC Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 53. Europe Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 55. United States Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 56. Canada Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 57. Mexico Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 58. Brazil Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 59. China Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 60. Japan Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 61. Korea Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 63. India Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 64. Australia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 65. Germany Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 66. France Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 67. UK Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 68. Italy Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 69. Russia Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 70. Egypt Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 71. South Africa Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 72. Israel Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 73. Turkey Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Dengue Vaccines Market Size 2025-2030 ($ millions)
Figure 75. Global Dengue Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Dengue Vaccines Market Size Market Share Forecast by Application (2025-2030)
